Actually, due to the known efficacy of SGLT-2 inhibitors on glycemic control in T2D, and the beneficial effects on body weight, we prescribed SGLT-2 inhibitors especially in those patients with a higher HbA1c or higher BMI score [6, 31]. Here, SLC5A2 is linked to type 2 diabetes mellitus.